MARKET

PHMMF

PHMMF

Pharma Mar Sa
OTCPK
93.00
NaN%
Closed 09:30 06/09 EDT
OPEN
--
PREV CLOSE
93.00
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
110.40
52 WEEK LOW
71.20
MARKET CAP
1.61B
P/E (TTM)
17.24
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PHMMF last week (0601-0605)?
Weekly Report · 2d ago
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN), Pharma Mar SA (OtherPHMMF) and Sotera Health (SHC)
TipRanks · 2d ago
EU clears PharmaMar’s Zepzelca combo for first‑line maintenance in aggressive lung cancer
TipRanks · 06/02 13:47
Weekly Report: what happened at PHMMF last week (0525-0529)?
Weekly Report · 06/01 09:00
Weekly Report: what happened at PHMMF last week (0518-0522)?
Weekly Report · 05/25 09:00
Pharma Mar Calls 2026 Shareholders’ Meeting to Approve 2025 Results and Refresh Board
TipRanks · 05/22 11:52
Weekly Report: what happened at PHMMF last week (0511-0515)?
Weekly Report · 05/18 09:00
Weekly Report: what happened at PHMMF last week (0504-0508)?
Weekly Report · 05/11 09:00
More
About PHMMF
Pharma Mar SA is a Spain-based integrated biopharmaceutical company focused on oncology and committed to research and development (R&D) of antitumor drugs of marine origin. The Company, through its subsidiaries, operates three business segments: Oncology, Diagnostics and RNA interference. The Oncology segment encompasses research, develop and market anti-tumor drugs. The Diagnostics segment includes the development and marketing of diagnostic kits. The RNA interference segment consist of the development of drugs with therapeutic activity based on reducing or silencing gene expression. The Company’s product portfolio includes Yondelis and ZEPZELCA. Yondelis (trabectedin) is indicated for the treatment of advanced soft tissue sarcoma, as well as for the treatment of relapsed platinum-sensitive ovarian cancer. ZEPZELCA (lurbinectedin) is indicated for the treatment of metastatic small cell lung cancer (SCLC) with disease progression. The Company is active globally.

Webull offers Pharma Mar SA stock information, including OTCPK: PHMMF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHMMF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHMMF stock methods without spending real money on the virtual paper trading platform.